Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia;Objawy neurobehawioralne we wczesnych postaciach otȩpień typu Alzheimera i naczyniopochodnych

Psychiatria Polska

Volumn 48, Issue 2, 2014, Pages 319-330

  Bidzan, Mariola ^a   Bidzan, Leszek ^b  

^a Uniwersytetu Gda skiego   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Aggression; Cognitive symptoms; Depression

Indexed keywords

AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DSM-IV; HUMAN; IRRITABILITY; MINI MENTAL STATE EXAMINATION; MOOD CHANGE; MULTIINFARCT DEMENTIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANXIETY DISORDERS; COMORBIDITY; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; GERIATRIC ASSESSMENT; HOMES FOR THE AGED; HUMANS; INCIDENCE; MALE; NEUROPSYCHOLOGICAL TESTS; NURSING HOMES; PSYCHOMOTOR AGITATION; SEVERITY OF ILLNESS INDEX;

EID: 84899532688     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC i wsp. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med. 2000; 343: 450-456.
2. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM i wsp. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005; 5: 404-411.
3. Durany N, Michel T, Kurt J, Cruz-Sanchez FF, Crevos-Navarro J, Riederer P. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int. J. Dev. Neurosci. 2000; 18: 807-813. (Pubitemid 32037055)
4. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino EZ i wsp. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
5. Waite LM, Broe GA, Grayson DA, Creasey H. Preclinical syndromes predict dementia: the Sydney older persons study. J. Neurol. Neurosurg. Psychiatry 2001; 71(3): 296-302. (Pubitemid 32772524)
6. Bäckman L, Small BJ. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project. Physiol. Behav. 2007; 10; 92(1-2): 80-86.
7. Holtmannspötter M, Peters N, Opherk C, Martin D, Herzog J, Brückmann H. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005; 36(12): 2559-2565.
8. Jones S, Laukka EJ, Small BJ, Fratiglioni L, Bäckman L. A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis. Dement. Geriatr. Cogn. Disord. 2004; 18(3-4): 233-239. (Pubitemid 39370296)
9. Laukka EJ, Jones S, Fratiglioni L, Bäckman L. Cognitive functioning in preclinical vascular dementia: a 6-year follow-up. Stroke 2004; 35(8): 1805-1809. (Pubitemid 38971855)
10. Cummings JL. The neuropsychiatry of Alzheimer's disease and related dementias. London: Martin Dunitz Ltd.; 2002.
11. Cohen-Mansfield J, Marx MS, Rosenthal AS. Dementia and agitation in nursing home residents: how are they related Psychol. Aging. 1990; 5: 3-8.
12. Beck C, Frank L, Chumbler NR, O'Sullivan P, Vogelpohl TS, Rasin J. Correlates of disruptive behavior in severely cognitively impaired nursing home residents . Gerontologist 1998; 38: 189-198. (Pubitemid 28169629)
13. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Neuropathologica 1991; 82: 259.
14. Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982; 32: 164-168. (Pubitemid 12223999)
15. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry 1982; 139: 1136-1139. (Pubitemid 12051593)
16. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189-198.
17. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 1984; 141: 1356-1364.
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory. Comprehensive assessment of psychology in dementia. Neurology 1994; 44: 2308-2314. (Pubitemid 24382728)
19. Wood S, Cummings JL, Hsu M-A, Barclay T, Wheatley MV, Yarema KT. The use of the Neuropsychiatric Inventory in Nursing Home residents. Am. J. Geriatr. Psychiatry 2000; 8: 75-83.
20. Diagnostic and statistical manual of mental disorders. Fourth edition. Washington, DC: APA; 1994.
21. Mc Khan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the suspicies of Department of Health Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939.
22. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH i wsp. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43(2): 250-260.
23. Hachinski VC. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; 2: 207-209.
24. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. J. Neurol. Neurosurg. Psychiatry 2004; 75(1): 61-71. (Pubitemid 38091270)
25. Kertesz A, Clydesdale S. Neuropsychological deficits in vascular dementia vs Alzheimer's disease. Frontal lobe deficits prominent in vascular dementia. Arch. Neurol. 1994; 51(12): 1226-1231. (Pubitemid 24369612)
26. Berg L, Morris C. Diagnosis. W: Terry RD, Katzman R, Bick L. red. Alzheimer disease. New York: Raven Press Ltd. s. 9-25.
27. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a threee-year prospective study. Arch. Neurol. 1985; 42: 894-896. (Pubitemid 15021580)
28. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J i wsp. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59: 364-370.
29. Devanand DP. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1999; 13(supl. 2): S3-S8.
30. Moritz DJ, Fox PJ, Luscombe FA, Kraemer HC. Neurological and psychiatric predictors of mortality in patients with Alzheimer disease in California. Arch. Neurol. 1997; 54: 878-885. (Pubitemid 27306625)
31. Burns A, Lewis G, Jacoby R, Levy R. Factors affecting survival in Alzheimer's disease. Psychol. Med. 1991; 21: 363-370.
32. Jagger C, Clarke M, Stone A. Predictors of survival with Alzheimer's disease: a community-based study. Psychol. Med. 1995; 25: 171-177.
33. Lopez OL, Boller F, Becker JT, Miller M, Reynolds CF. Alzheimer's disease and depression: neuropsychological impairment and progression of the illness. Am. J. Psychiatry 1990; 147: 855-860. (Pubitemid 20210395)
34. Rockwood K, Moorhouse PK, Song X, MacKnight C, Gauthier S, Kertesz A i wsp. Consortium to Investigate Vascular Impairment of Cognition (CIVIC) Cohort. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. J. Neurol. Sci. 2007; 252(2): 106-112.
35. Crook T, Petrie W, Wells C, Massari-DC. Effects of phosphatidylserine in Alzheimer's disease. Psychopharmacol. Bull. 1992; 28(1): 61-66.
36. Cummings JL, Back C. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am. J. Geriatr. Psychiatry 1998; 6: S64-S78.
37. Gorman DG, Read S, Cummings JL. Cholinergic therapy of behavioral disturbances in Alzheimer's disease. Neuropsychiatr. Neuropsychol. Behav. Neurol. 1993; 6: 229-234. (Pubitemid 23363348)
38. Sunderland T, Tariot PN, Cohen RM. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. Arch. Gen. Psychiatry 1987; 44: 418-426. (Pubitemid 17064486)
39. Sunderland T, Tariot PN, Newhouse PA. Differential responsivity of mood, behavior, and cognition to cholinergic agents in the elderly neuropsychiatric populations. Brain Res. Rev. 1988; 13: 371-389. (Pubitemid 19024354)
40. Gauthier S, Bouchard R, Lamontagne A. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease: results of a Canadian double-blind, cross-over, multicenter study. N. Engl. J. Med. 1990; 322: 1272-1276. (Pubitemid 20152490)
41. Chiu MJ, Chen TF, Yip PK, Hua MS, Tang LY. Behavioral and psychologic symptoms in different types of dementia. J. Formos. Med. Assoc. 2006; 105(7): 556-562.
42. O'Brien J. Behavioral symptoms in vascular cognitive impairment and vascular dementia. Int. Psychogeriatr. 2003; 15(supl. 1): 133-138.
43. Bidzan L, Bidzan M, Pa̧chalska M. Aggressive and impulsive behavior in Alzheimer's disease and progression of dementia. Med. Sci. Monit. 2012; 18(3): 190-197.
44. Backman L, Small B, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001; 124: 96-102. (Pubitemid 32055992)
45. Hall CB, Ying J, Kuo L, Sliwinski M, Buschke H, Katz M i wsp. Estimation of bivariate measurements having different change points, with application to cognitive ageing. Stat. Med. 2001; 30: 3695-3714.